Cardiac function, metabolism and perfusion in Duchenne and Becker muscular dystrophy

Neuromuscular Disorders

Volumn 6, Issue 4, 1996, Pages 237-246

  Quinlivan, R M ^a   Lewis, P ^a   Marsden, P ^a   Dundas, R ^b   Robb, S A ^a   Baker, E ^a   Maisey, M ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Becker muscular dystrophy; Cardiomyopathy; Duchenne muscular dystrophy; Positron emission tomography

Indexed keywords

AMMONIA; FLUORODEOXYGLUCOSE F 18; TRACER;

ADOLESCENT; ADULT; AGE; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHILD; CLINICAL ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GLUCOSE METABOLISM; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE EXTRASYSTOLE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PR INTERVAL; PRIORITY JOURNAL; Q WAVE; QT INTERVAL; ST SEGMENT DEPRESSION;

EID: 0030221228     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-8966(96)00007-7     Document Type: Article

References (36)

1. 1. Koenig M, Monaco A, Kunkel L. The complete sequencing of dystrophin predicts a rod shaped cytoskeletal protein. Cell 1990; 50: 219-226.
2. 2. Monaco A, Bertelson C, Liechti-Gallati S, Moser H. An explanation for the phenotypic differences between cases bearing partial deletions of the DMD locus. Genomics 1988; 2: 90-94.
3. 3. K Frankel, R. Rosser. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Human Path 1976; 7: 375-386.
4. 4. Mukoyama M, Kondo K, Hizawa K, Nishitana H, the DMDR group. Life spans of Duchenne muscular dystrophy patients in the hospital care programme in Japan. J Neurol Sci 1987; 81: 155-158.
5. 5. Nagai T. Prognostic evaluation of congestive heart failure in patients with Duchenne muscular dystrophy. Jap Circ J 1989; 53: 406-419.
6. 6. Nigro G. The importance of cardiological studies in the muscular dystrophies. Cardiomyology 1983; 2: 209-219
7. 7. Heymsfield S B, McNish T, Perkins J V, Felner J M. Sequence of changes in Duchenne muscular dystrophy. Am Heart J 1978; 95 : 283-294.
8. 8. D'Orsagna L, O'Shea J, Miller G. Cardiomyopathy of Duchenne muscular dystrophy. Paed Cardiol 1988; 9: 205-213.
9. 9. Steare S E, Benatar A, Dubowitz V. Subclinical cardiomyopathy in Becker muscular dystrophy. Br Heart J 1992; 68: 304-308.
10. 10. Levin R, Nahara K. Right axis deviation and anterior wall thallium-201 defect in Becker's muscular dystrophy. Am J Cardiol 1985; 56: 203-204.
11. 11. De Visser M, de Voogt W, La Riviere G. The heart in Becker muscular dystrophy, fascioscapulohumeral dystrophy and Bethlem myopathy. Muscle Nerve 1983; 6: 253-262.
12. 12. Nigro G, Comi L I, Politano L, Limongelli F. et al. Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 1995; 18: 283-291
13. 13. Katlyer B C, Misra S, Somani P N, Chaterji A M. Congestive cardiomyopathy in a family of Becker's X linked muscular dystrophy. Postgrad Med J 1977; 53: 12-15.
14. 14. Sakata C, Sunohara N, Nonaka I, Arahata K, Sugita H. A case of Becker muscular dystrophy presenting with cardiac failure as the initial symptom. Rinsho. Shinkeigaku 1990 30: 210-213 (Japanese).
15. 15. Quinlivan R, Dubowitz V. Cardiac transplantation in Becker muscular dystrophy. Neuromusc Disord 1993; 3: 217-221.
16. 16. Casazzo F, Bambilla S G, Salvato A, Moraidi L, Gonda E, Bonacina E. Cardiac transplantation in Becker muscular dystrophy. J Neurol 1988; 235: 496-498.
17. 17. Donofrio D, Challa V, Hackshaw B, Mills S, Cordwell R. Cardiac transplantation in a patient with Becker muscular dystrophy and cardiomyopathy. Arch Neurol 1989; 46: 705-707.
18. 18. Schelbert H, Phelps M, Hoffman E, Huang S, Selin C, Kuhl D. Regional myocardial perfusion with N-13 labelled ammonia and positron emission computerised axial tomography. Am J Cardiol 1979; 43: 209-218.
19. 19. Tilyiou S M. The evolution of Positron Emission Tomography. J Nuc Med 1991; 32: 15-26.
20. 20. Schelbert H R, Phelps M E, Huang S C et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981; 63: 1259-1272.
21. 21. Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565-578.
22. 22. Perloff J K, Henze E, Schelbert H. Alterations in regional myocardial metabolism, perfusion and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. Circulation 1984; 69: 33-42.
23. 23. Wagner H. Clinical PET: It's time has come. J Nucl Med 1991; 32: 561-564.
24. 24. Gould K L. Clinical cardiac positron emission tomography: state of the art. Circulation 1991; 84 (suppl 1): 1-22-1-36.
25. 25. McGivney W T. Hurdles to technology diffusion: what are the expectations for PET? J Nucl Med 1991; 32: 660-664.
26. 26. Porenta G, Kuhle W, Czernin J, Ratib O, Brunken R C, Phelps M E, Schelbert H R. Semiquantitative assessment of myocardial blood flow and viability using polar map display of cardiac PET images. J Nucl Med 1992; 33; 1628-1636.
27. 27. Choi Y, Huang S C. A simplified method for quantification of myocardial blood flow using N-13 ammonia dynamic PET. J Nucl Med 1993; 34: 488-97.
28. 28. Practical Statistics for Medical Researchers. Altman D G. Chapman and Hall, 1991: 210-211.
29. 29. Perloff J. Cardiac Rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 23 patients. J Am Coll Cardiol 1994; 3: 1263-1268.
30. 30. Yamamoto S, Matsushima H, Suzuki A, Sotobata I, Toshikatsu I, Matsuoka Y. A comparative study of thallium-201 single-photon emission computed tomography and electrocardiography in Duchenne and other types of muscular dystrophy. Am J Cardiol 1988; 61: 836-834.
31. 31. Nagamachi S, Inoue K, Jinnouchi S. et al. Cardiac involvement in progressive muscular dystrophy (Becker type, limb-girdle type and Fukuayama type) evaluated by radionuclide method. Ann Nucl Med 1994; 8: 71-74.
32. 32. Schwaiger M. Myocardial perfusion imaging with PET. J Nucl Med 1994; 36 (4); 693-698.
33. 33. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive cardiac failure. N Engl J Med 1991; 325: 293-302.
34. 34. Partridge T A. What does study of the mdx mouse tell us about the myopathic consequences of dystrophin-deficiency? Muscle Nerve 1994; supp.1: S70.
35. 35. Perloff J K, Roberts W C, DeLeon A C et al. The distinctive electrocardiogram of Duchenne progressive muscular dystrophy. Am J Med 1967; 42: 179-188.
36. 36. Gorospe J R, Thorpe M D, Hinckley J, Kornegay J M, Hoffman E P. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs and mice. J Neural Sci 1994; 122 (1) 44-56.